Global Female Contraception Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- Published Date: 2021-04-23
- Report ID: 105170
- Pages: 109
-
Format:
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Markets analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Female Contraception Drug market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Female Contraception Drug Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Female Contraception Drug Market
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer AG
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd
...
Major Type of Female Contraception Drug Covered in Prudent Markets report:
AG-890
Amphora
BAY-1007626
Drospirenone
Others
Application Segments Covered in Prudent Markets Market
Clinic
Hospital
Homecare
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Female Contraception Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 AG-890 -Product Introduction and Major Manufacturers
1.1.2 Amphora -Product Introduction and Major Manufacturers
1.1.3 BAY-1007626 -Product Introduction and Major Manufacturers
1.1.4 Drospirenone -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Female Contraception Drug Status and Prospect (2015-2026)
2.1.1 China Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Female Contraception Drug Status and Prospect (2015-2026)
2.2.1 EU Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Female Contraception Drug Status and Prospect (2015-2026)
2.3.1 USA Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Female Contraception Drug Status and Prospect (2015-2026)
2.4.1 Japan Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Female Contraception Drug Status and Prospect (2015-2026)
2.5.1 India Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Female Contraception Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Female Contraception Drug Status and Prospect (2015-2026)
2.7.1 South America Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Female Contraception Drug Status and Prospect (2015-2026)
2.8.1 Female Contraception Drug Market Size and Growth Rate (2015-2026)
2.8.2 Female Contraception Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Female Contraception Drug Market Assessment by Segment
3.1 Global Female Contraception Drug Capacity and Growth Rate
3.2 Global Female Contraception Drug Sales by Type
3.3 Global Female Contraception Drug Sales Revenue by Type
3.4 Global Female Contraception Drug Consumption by Application
4 Global Female Contraception Drug Market Assessment by Regions
4.1 Global Female Contraception Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Female Contraception Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Female Contraception Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Female Contraception Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Female Contraception Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Female Contraception Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Female Contraception Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Female Contraception Drug Sales Revenue Market Share of Manufacturers (2019-2020)
7 Female Contraception Drug Competitive Analysis
7.1 Addex Therapeutics Ltd
7.1.1 Addex Therapeutics Ltd Company Profiles
7.1.2 Addex Therapeutics Ltd Product Introduction
7.1.3 Addex Therapeutics Ltd Female Contraception Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Agile Therapeutics Inc
7.2.1 Agile Therapeutics Inc Company Profiles
7.2.2 Agile Therapeutics Inc Product Introduction
7.2.3 Agile Therapeutics Inc Female Contraception Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Bayer AG
7.3.1 Bayer AG Company Profiles
7.3.2 Bayer AG Product Introduction
7.3.3 Bayer AG Female Contraception Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Evofem Inc
7.4.1 Evofem Inc Company Profiles
7.4.2 Evofem Inc Product Introduction
7.4.3 Evofem Inc Female Contraception Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Hervana Ltd
7.5.1 Hervana Ltd Company Profiles
7.5.2 Hervana Ltd Product Introduction
7.5.3 Hervana Ltd Female Contraception Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Mithra Pharmaceuticals SA
7.6.1 Mithra Pharmaceuticals SA Company Profiles
7.6.2 Mithra Pharmaceuticals SA Product Introduction
7.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Orbis Biosciences Inc
7.7.1 Orbis Biosciences Inc Company Profiles
7.7.2 Orbis Biosciences Inc Product Introduction
7.7.3 Orbis Biosciences Inc Female Contraception Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Teva Pharmaceutical Industries Ltd
7.8.1 Teva Pharmaceutical Industries Ltd Company Profiles
7.8.2 Teva Pharmaceutical Industries Ltd Product Introduction
7.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Viramal Ltd
7.9.1 Viramal Ltd Company Profiles
7.9.2 Viramal Ltd Product Introduction
7.9.3 Viramal Ltd Female Contraception Drug Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
8 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
